
Peter Thiel
Peter Thiel is the President of Clarium Capital Management, a hedge fund with $6 billion under mangement. Peter co-founded PayPal and served as its Chairman and CEO until the company's sale to eBay in October 2002 for $1.5 billion. Peter's experience in finance includes managing a successful hedge fund, trading derivatives at CS Financial Products, and practicing securities law at Sullivan & Cromwell. Peter sits on the Board of Directors of the Pacific Research Institute and on the Board of Visitors of Stanford Law School. Peter received his BA in Philosophy and his JD from Stanford.
View Older Stories
-
N26 appoints Silicon Valley entrepreneur Gilles BianRosa as Chief Product Officer
-
Top Psychedelic Penny Stocks To Watch After Latest Big Pharma Deal
-
Nanotronics Appoints Jodi Shelton, Global Semiconductor Alliance co-founder and CEO, to Board of Advisors
-
Flex Logix Raises $55M Series D Financing As It Accelerates Market Adoption of AI Inference and eFPGA Solutions
-
Genesis Prize Co-Founder Stan Polovets Steps Down as Chairman of Anchiano Therapeutics after Company Posts 630% Return in 12 Months
-
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
-
Chemomab Completes Merger with Anchiano Therapeutics
-
SafeGraph Raises $45M Series B to Become the Ultimate Destination for Physical Places Data
-
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
-
ForSight Robotics Raises $10 Million from Eclipse Ventures and Mithril Capital in Seed Round
-
Exclusive: Forward Health valued at over $1 billion in latest funding from SoftBank, others - source
-
N26 Launches Frictionless U.S. Rewards Program to Help Customers Easily Earn Cash Back with Everyday Spending
-
Psychedelics & Cannabis Have Triggered A Mad Dash In The Market & 1 Company Stands To Capitalize
-
Neobroker nextmarkets receives $30 million in Series B funding round
-
Alphabet-backed Oscar Health valued at $7.09 billion in lackluster debut
-
Peter Thiel Sold Half a Billion in Palantir (PLTR) Stock as Lockup Expired
-
BlackSky to Come Public on Merger with SPAC Osprey Technology Acquisition Corp. (SFTW)
-
BlackSky, a Leading Real-Time Geospatial Intelligence, Imagery and Data Analytics Company, to List on NYSE Through a Merger With Osprey Technology Acquisition Corp.
-
Big data firm Palantir signals slower annual revenue growth, shares fall
-
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
-
$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial
-
Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome
-
Forge Launches Forge Company Solutions To Help Private Companies Run Customized Liquidity Events
-
Chemomab Announces First Patient Enrolled in Phase IIa Study of CM-101 for the Treatment of Patients with Primary Sclerosing Cholangitis
-
Forge Appoints Head of Data to Expand Accuracy and Transparency for Private Market Companies and Investors
-
N26 celebrates 7 million customers globally
-
Top Penny Stocks To Watch For 2021 If You're Following Mushroom Stocks
-
Former Google (GOOGL) Engineer Anthony Lewandowski Among Those Who Are Pardoned by Trump on His Last Day in Office
-
Trump pardons former Google self-driving car engineer Levandowski
-
Rescale Named to Y Combinator's Top Companies List
-
NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program
-
Qualcomm To Acquire Mithril Portfolio Company NUVIA
-
Affirm Holdings prices U.S. IPO above target range, raises $1.2 billion
-
Fintech startup Affirm aims for over $9 billion valuation in U.S. IPO
-
Chemomab Announces Positive Phase Ib Results of its SPARK study testing CM-101 in NAFLD patients
-
4 Top Penny Stocks To Watch For Q1 2021
-
U.S. approves NYSE listing plan to cut out Wall Street middlemen
-
Analysis: New blank-check firms arm up for Asian unicorn hunt
-
Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform
-
Exclusive: Indonesia e-commerce giant Tokopedia aims for $1 billion dual U.S., domestic IPO - sources
-
Forge Sees Record Quarter with More Than 1,200 Trades, Hits $8.8B in Transaction Volume
-
Paxos Raises $142 Million in Series C Funding
-
German fintech N26 eyes more fundraising before IPO in 2023 -CEO
-
E-commerce firm Wish sees shares fall 5% in market debut
-
Neo Financial Raises $50 Million in Series A Funding and Debt Financing
-
Layer1 Co-Founder Rejoins Company as CEO and Chairman of the Board
-
E-commerce firm Wish raises $1.1 billion in IPO
-
Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement
-
Bridgetown Holdings (BTWN) SPAC Said to Weigh Up to $10 Billion Tokopedia Deal - Bloomberg
-
4 Magic Mushroom Stocks You Might've Missed In December 2020